Search | Page 21 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS (UPCI 13-165)

    ... Associated Drug(s):  Azacitidine Phase:  ...

    Clinical Trial last updated 04/29/2016 - 10:26am.

  2. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... Alemtuzumab Azacitidine Fludarabine ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  3. Nursing Education Modules on MDS Disease Management and Patient Education

    ... chelation Treatment options for high-risk MDS – azacitidine , decitabine , allo-HSCT, clinical trials MDS ...

    Page last updated 04/27/2015 - 2:44pm.

  4. Clinical Trials Report for January 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 12/30/2014 - 10:45am.

  5. Patient Education Materials

    ... treatments using the 3 FDA-approved drugs for MDS – azacitidine (Vidaza®), decitabine (Dacogen®) and lenalidomide ...

    Page last updated 11/06/2013 - 4:28pm.

  6. Clinical Trials Report for March 2015

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of this ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 03/02/2015 - 10:06am.

  7. Aristoteles Giagounidis, MD

    ... approaches. These include lenalidomide and azacitidine in myelodysplastic syndromes, deferasirox in iron ...

    Page last updated 01/20/2012 - 3:30pm.

  8. Clinical Trials Report for December 2014

    ... Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) The goal of ... study is to compare how 2 different drugs, decitabine and azacitidine, when given on a shorter than standard dosing schedule, may help to ...

    Page last updated 11/25/2014 - 3:33pm.

  9. Dr. Matt Walter on Mentorship

    ... MDS patients with a combination of drugs, vosaroxin and azacitidine .  Vosaroxin has a different mechanism of action than azacitidine. It can cause DNA damage to MDS cells. We will determine whether a ...

    Interview last updated 07/20/2015 - 1:04pm.

  10. Research Retrospective for AA&MDSIF 30th Anniversary - Dr. Mikkael Sekeres

    ... 2009 demonstrated that for the first time, an MDS drug, azacitidine , has provided a survival advantage. We have a rising number ...

    Interview last updated 05/08/2013 - 2:51pm.